A detailed history of Los Angeles Capital Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 242,875 shares of BSX stock, worth $20.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
242,875
Previous 188,737 28.68%
Holding current value
$20.5 Million
Previous $12.9 Million 44.69%
% of portfolio
0.07%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$67.33 - $77.71 $3.65 Million - $4.21 Million
54,138 Added 28.68%
242,875 $18.7 Million
Q1 2024

Apr 05, 2024

BUY
$57.6 - $68.62 $10.3 Million - $12.2 Million
178,349 Added 1716.88%
188,737 $12.9 Million
Q4 2023

Feb 06, 2024

BUY
$48.64 - $57.81 $5,496 - $6,532
113 Added 1.1%
10,388 $600,000
Q3 2023

Nov 06, 2023

SELL
$50.19 - $54.68 $4.16 Million - $4.53 Million
-82,919 Reduced 88.97%
10,275 $542,000
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $4.02 Million - $4.41 Million
80,781 Added 650.78%
93,194 $5.04 Million
Q1 2023

May 04, 2023

SELL
$45.09 - $50.03 $4.26 Million - $4.73 Million
-94,460 Reduced 88.39%
12,413 $621,000
Q4 2022

Feb 06, 2023

BUY
$39.56 - $47.22 $510,086 - $608,854
12,894 Added 13.72%
106,873 $4.95 Million
Q3 2022

Nov 02, 2022

BUY
$36.71 - $109.66 $1.41 Million - $4.21 Million
38,360 Added 68.97%
93,979 $3.64 Million
Q2 2022

Aug 05, 2022

SELL
$35.24 - $47.1 $40,279 - $53,835
-1,143 Reduced 2.01%
55,619 $2.07 Million
Q1 2022

May 06, 2022

BUY
$40.9 - $45.1 $332,680 - $366,843
8,134 Added 16.73%
56,762 $2.51 Million
Q4 2021

Feb 03, 2022

SELL
$38.07 - $44.87 $88,322 - $104,098
-2,320 Reduced 4.55%
48,628 $2.07 Million
Q3 2021

Nov 08, 2021

BUY
$41.23 - $45.88 $289,970 - $322,674
7,033 Added 16.02%
50,948 $2.21 Million
Q2 2021

Aug 05, 2021

SELL
$38.58 - $44.24 $3.81 Million - $4.37 Million
-98,761 Reduced 69.22%
43,915 $1.88 Million
Q1 2021

May 05, 2021

SELL
$35.27 - $39.67 $4 Million - $4.5 Million
-113,414 Reduced 44.29%
142,676 $5.51 Million
Q4 2020

Feb 04, 2021

BUY
$33.15 - $41.97 $32,056 - $40,584
967 Added 0.38%
256,090 $9.21 Million
Q3 2020

Nov 02, 2020

SELL
$34.44 - $42.23 $15.6 Million - $19.1 Million
-451,742 Reduced 63.91%
255,123 $9.75 Million
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $1.15 Million - $1.49 Million
38,113 Added 5.7%
706,865 $24.8 Million
Q1 2020

May 04, 2020

SELL
$25.83 - $45.71 $15.9 Million - $28.2 Million
-616,839 Reduced 47.98%
668,752 $21.8 Million
Q4 2019

Feb 07, 2020

SELL
$37.87 - $45.37 $4.87 Million - $5.84 Million
-128,618 Reduced 9.09%
1,285,591 $58.1 Million
Q3 2019

Nov 07, 2019

SELL
$40.31 - $43.45 $23.4 Million - $25.2 Million
-580,934 Reduced 29.12%
1,414,209 $57.5 Million
Q2 2019

Jul 29, 2019

SELL
$34.91 - $42.98 $3.51 Million - $4.32 Million
-100,540 Reduced 4.8%
1,995,143 $85.8 Million
Q1 2019

Apr 25, 2019

SELL
$32.91 - $40.75 $2.58 Million - $3.2 Million
-78,537 Reduced 3.61%
2,095,683 $80.4 Million
Q4 2018

Feb 11, 2019

SELL
$31.73 - $39.04 $366,481 - $450,912
-11,550 Reduced 0.53%
2,174,220 $76.8 Million
Q3 2018

Nov 05, 2018

BUY
$32.83 - $38.63 $6.61 Million - $7.78 Million
201,430 Added 10.15%
2,185,770 $84.2 Million
Q2 2018

Jul 31, 2018

BUY
$26.84 - $34.32 $46,621 - $59,613
1,737 Added 0.09%
1,984,340 $64.9 Million
Q1 2018

Apr 27, 2018

SELL
$25.2 - $28.54 $76,230 - $86,333
-3,025 Reduced 0.15%
1,982,603 $54.2 Million
Q4 2017

Feb 05, 2018

SELL
$24.79 - $29.8 $25.1 Million - $30.2 Million
-1,012,886 Reduced 33.78%
1,985,628 $49.2 Million
Q3 2017

Nov 06, 2017

SELL
$26.26 - $29.17 $1.15 Million - $1.28 Million
-43,950 Reduced 1.44%
2,998,514 $87.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
3,042,464
3,042,464 $84.3 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.